FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Beryl Drugs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524606 P/E (TTM) :47.78
ISIN Demat:INE415H01017 Div & Yield %:0 EPS (TTM) :0.46
Book Value (RS) :18.6259045 Market Cap (Rs Cr.):11.15 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Sep 2025)		 Quarter Ended
(Sep 2024)		 Quarter Ended
(% Var)
Sales 5.12 5.61 -8.73
Other Income 0.00 0.00 0.00
PBIDT 0.73 0.57 28.07
Interest 0.08 0.12 -33.33
PBDT 0.65 0.44 47.73
Depreciation 0.39 0.33 18.18
PBT 0.26 0.11 136.36
Tax 0.11 0.12 -8.33
Deferred Tax 0.14 -0.02 0.00
PAT 0.01 0.01 0.00

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)